Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss
Open Access
- 17 July 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0181230
Abstract
The extracellular acidic milieu in bones results in activation of osteoclasts (OC) and inhibition of osteoblasts (OB) causing a net loss of calcium from the skeleton and the deterioration of bone microarchitecture. Alkalinization through supplementation with potassium citrate (K citrate) has been proposed to limit the osteopenia progression, even though its pharmacological activity in bone microenvironment is not well defined. We evaluated if K citrate was able to prevent the adverse effects that acidic milieu induces on bone cells. OC and OB were maintained in neutral (pH 7.4) versus acidic (pH 6.9) culture medium, and treated with different K citrate concentrations. We evaluated the OC differentiation at seven days, by counting of multinucleated cells expressing tartrate-resistant acid phosphatase, and the activity of mature OC at 14 days, by quantifying of collagen degradation. To evaluate the effects on OB, we analyzed proliferation, mineralization, and expression of bone-related genes. We found that the low pH increased OC differentiation and activity and decreased OB function. The osteoclastogenesis was also promoted by RANKL concentrations ineffective at pH 7.4. Non-cytotoxic K citrate concentrations were not sufficient to steadily neutralize the acidic medium, but a) inhibited the osteoclastogenesis, the collagen degradation, and the expression of genes involved in RANKL-mediated OC differentiation, b) enhanced OB proliferation and alkaline phosphatase expression, whereas it did not affect the in vitro mineralization, and c) were effective also in OC cultures resistant to alendronate, i.e. the positive control of osteoclastogenesis inhibition. In conclusion, K citrate prevents the increase in OC activity induced by the acidic microenvironment, and the effect does not depend exclusively on its alkalizing capacity. These data provide the biological basis for the use of K citrate in preventing the osteopenia progression resulting from low-grade acidosis.Keywords
Funding Information
- Fondazione del Monte di Bologna e Ravenna
- "5 per mille" 2014
This publication has 63 references indexed in Scilit:
- Nutritional disturbance in acid–base balance and osteoporosis: a hypothesis that disregards the essential homeostatic role of the kidneyBritish Journal of Nutrition, 2013
- Potassium citrate supplementation results in sustained improvement in calcium balance in older men and womenJournal of Bone and Mineral Research, 2012
- Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)Journal of Bone and Mineral Research, 2011
- IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursorsExperimental Cell Research, 2011
- Evolution of Allosteric Citrate Binding Sites on 6-phosphofructo-1-kinasePLOS ONE, 2010
- The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditionsJournal of Bone and Mineral Metabolism, 2008
- Measures of Renal Function, BMD, Bone Loss, and Osteoporotic Fracture in Older Adults: The Rancho Bernardo StudyJournal of Bone and Mineral Research, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humansCalcified Tissue International, 1993
- Osteogenesis and the pH of the osseous circulationCalcified Tissue International, 1968